Spinraza, is the first FDA-approved drug that increases SMN protein content in motor nerve cells; deficiency of SMN in these cells is the underlying cause of SMA. Spinraza is now available ...

Spinraza is a medication used in children (including newborns) and adults to treat spinal muscular atrophy. Treatment begins with four loading doses, followed by one maintenance dose every 4 months.

Spinraza (nusinersen) is a prescription drug used to treat spinal muscular atrophy. Spinraza can cause side effects that range from mild to serious. Examples include headache and fever. Keep reading ...

US_Spinraza The CHERISH study was a multicenter, randomized, double-blind, sham-procedure controlled study to evaluate the safety and efficacy of Spinraza in children with later-onset SMA (n=126) aged ...